e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
WHO guidelines in TB and clinical practice
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium
Pierpaolo de Colombani (Copenhagen, Denmark), Pierpaolo De Colombani, Stephane Dupasquier, Giovanni Battista Migliori, Masoud Dara
Source:
International Congress 2015 – WHO guidelines in TB and clinical practice
Session:
WHO guidelines in TB and clinical practice
Session type:
Poster Discussion
Number:
1535
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pierpaolo de Colombani (Copenhagen, Denmark), Pierpaolo De Colombani, Stephane Dupasquier, Giovanni Battista Migliori, Masoud Dara. Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium. Eur Respir J 2015; 46: Suppl. 59, 1535
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
The health economics of treating MDR-TB in the Indian private sector
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016
The cost of tuberculosis in Denmark
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
Knowledge and attitude about tuberculosis disease in a health workers population
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Management of tuberculosis (TB) at a district general hospital: An audit of practice
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
A study of tuberculosis in an expatriate Nepalese community in South-East London
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Impact and management of TB childhood outbreaks in EU/EEA
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
The European union standards for tuberculosis care: Do they need an update?
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
The global response to rifampicin-resistant tuberculosis: Current situation and recent trends
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Transmission pattern of MDR-TB in Singapore 2005-2015
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Knowledge and practices of hospital employees on tuberculosis
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Awareness and knowledge of pediatricians in Cebu City of the national tuberculosis control program in the management of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Latent TB in healthcare workers from high prevalence countries at city hospital Sunderland foundation trust (CHSFT); epidemiology and management
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Childhood tuberculosis outbreaks in EU/EEA: A systematic review
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
European framework to decrease the burden of TB/HIV
Source: Eur Respir J 2004; 24: 493-501
Year: 2004
Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Russian-language e-learning and decision-support app for mobile devices on tuberculosis and lung health for primary care workers in Belarus
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Outbreak of multidrug-resistant TB in a cyber-gaming cafe
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
MDR TB treatment results of GFATM program implementation in Tomsk, Russia
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept